Global Reporter Gene Assay Market to Reach $11.5 Billion by 2030
The global market for Reporter Gene Assay estimated at US$7.9 Billion in the year 2022, is projected to reach a revised size of US$11.5 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2022-2030. Luciferase Assays, one of the segments analyzed in the report, is projected to record 5.8% CAGR and reach US$4.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Fluorescent Protein-Related Assays segment is readjusted to a revised 5.3% CAGR for the next 8-year period.
The U.S. Market is Estimated at $2.3 Billion, While China is Forecast to Grow at 4.2% CAGR
The Reporter Gene Assay market in the U.S. is estimated at US$2.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2030 trailing a CAGR of 4.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 3.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.Select Competitors (Total 32 Featured) -
- Abcam PLC
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Biotium
- Danaher Corporation
- Genecopoeia, Inc.
- Geno Technology, Inc.
- Invivogen
- Merck KGaA
- Perkinelmer
- Promega Corporation
- Promocell
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Reporter Gene Assay - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Reporter Gene Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 2: World 8-Year Perspective for Reporter Gene Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
- Table 3: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 4: World 8-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 5: World Reporter Gene Assay Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- Table 6: World Recent Past, Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 7: World 8-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 8: World Recent Past, Current & Future Analysis for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 9: World 8-Year Perspective for Hospital & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 11: World 8-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 12: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 13: World 8-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 14: World Recent Past, Current & Future Analysis for In-vitro Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 15: World 8-Year Perspective for In-vitro Studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Luciferase Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 17: World 8-Year Perspective for Luciferase Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 18: World Recent Past, Current & Future Analysis for Fluorescent Protein-Related Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 19: World 8-Year Perspective for Fluorescent Protein-Related Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 20: World Recent Past, Current & Future Analysis for Chloramphenicol Acetyltransferase Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 21: World 8-Year Perspective for Chloramphenicol Acetyltransferase Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 22: World Recent Past, Current & Future Analysis for Beta-Galactosidase Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 23: World 8-Year Perspective for Beta-Galactosidase Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 24: World Recent Past, Current & Future Analysis for Beta-Glucuronidase Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 25: World 8-Year Perspective for Beta-Glucuronidase Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 26: World Recent Past, Current & Future Analysis for Other Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 27: World 8-Year Perspective for Other Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
UNITED STATES
- Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 28: USA Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 29: USA 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
- Table 30: USA Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 31: USA 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
- Table 32: USA Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 33: USA 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
CANADA
- Table 34: Canada Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 35: Canada 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
- Table 36: Canada Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 37: Canada 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
- Table 38: Canada Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 39: Canada 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
JAPAN
- Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 40: Japan Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 41: Japan 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
- Table 42: Japan Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 43: Japan 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
- Table 44: Japan Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: Japan 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
CHINA
- Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 46: China Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 47: China 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
- Table 48: China Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 49: China 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
- Table 50: China Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 51: China 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
EUROPE
- Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 52: Europe Recent Past, Current & Future Analysis for Reporter Gene Assay by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 53: Europe 8-Year Perspective for Reporter Gene Assay by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
- Table 54: Europe Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 55: Europe 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
- Table 56: Europe Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 57: Europe 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
- Table 58: Europe Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 59: Europe 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
FRANCE
- Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 60: France Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 61: France 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
- Table 62: France Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 63: France 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
- Table 64: France Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 65: France 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
GERMANY
- Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 66: Germany Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 67: Germany 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
- Table 68: Germany Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 69: Germany 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
- Table 70: Germany Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 71: Germany 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
ITALY
- Table 72: Italy Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 73: Italy 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
- Table 74: Italy Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 75: Italy 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
- Table 76: Italy Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 77: Italy 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
UNITED KINGDOM
- Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 78: UK Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 79: UK 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
- Table 80: UK Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 81: UK 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
- Table 82: UK Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 83: UK 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
REST OF EUROPE
- Table 84: Rest of Europe Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 85: Rest of Europe 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
- Table 86: Rest of Europe Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 87: Rest of Europe 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
- Table 88: Rest of Europe Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 89: Rest of Europe 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
ASIA-PACIFIC
- Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 90: Asia-Pacific Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 91: Asia-Pacific 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
- Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 93: Asia-Pacific 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
- Table 94: Asia-Pacific Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 95: Asia-Pacific 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
REST OF WORLD
- Table 96: Rest of World Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 97: Rest of World 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
- Table 98: Rest of World Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 99: Rest of World 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
- Table 100: Rest of World Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 101: Rest of World 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abcam PLC
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Biotium
- Danaher Corporation
- Genecopoeia, Inc.
- Geno Technology, Inc.
- Invivogen
- Merck KGaA
- Perkinelmer
- Promega Corporation
- Promocell
- Thermo Fisher Scientific, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 88 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 7.9 Billion |
| Forecasted Market Value ( USD | $ 11.5 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
